Back to Journals » Drug Design, Development and Therapy » Volume 15

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]

Total article views   Abstract views HTML views PDF downloads Totals
526 Dovepress* 358 168+ 59 526
Totals 358 168 59 526
*Since 12 February 2021
+Since July 2016

View citations on Google Scholar